“showed a trend”

16 In our study, the subgroup of patients with an initial FEV 1 35% to 65% of predicted showed a trend to benefit from augmentation therapy ( P = 0.07).

This is consistent with a reported reduction in reversal frequency following starvation [38] and we also found that food-deprived worms showed a trend towards a reduction in reversal compared to well-fed worms in the food race ( Figure 6D ; p = 0.07).

Q-PCR results showed a trend toward reduced viral burden in blood of mice treated with aIL-10r mAb prior to intraperitoneal WNV infection ( Figure 3 A , p = 0.07).

There was no difference in the overall response rate between the 9 or 18 μg/kg/day cohorts; however, a subset analysis of patients with stage IIB disease or higher, showed a trend towards higher response ( P = 0.07).

The differential expression of SDCBP between metastatic and non-metastatic patients (median 9484 as compared to 8330 as average of normalized intensity values) showed a trend to statistical significance (P = 0.07) in our cohort ( Fig. 1 C ).

Analysis of fasting C-peptide within each group as a function of time showed a trend toward an increase in function ( P = 0.07) over the first posttransplant month only in the animals that received intraportal islet/MSC.

Another finding was that older adults, in general, showed a trend toward lower P1 amplitudes—especially at the 100 ms SOA ( p < 0.07).

In contrast, the distribution of the MYH9 polymorphism in recipients showed a trend toward higher risk of BPAR (31.6% in CC, 32.4% in CA, 39.3% in AA; p = 0.07) ( Fig. 2A ).

Fluorescence was higher with rAAV2/5 than rAAV2/Rec3 (p = 0.04) and showed a trend of superiority over AAV2/Rec2 (p = 0.07).

Although underpowered to investigate the relationship, the A 1c -Derived Average Glucose (ADAG) study showed a trend ( P < 0.07) toward higher HbA 1c in people of African background, independent of chronic glycemia, which was measured using a combination of continuous glucose monitoring and frequent capillary glucose testing ( 17 ).

Conversely, the Anyplex TM II HPV28 assay showed a trend toward higher detection of HPV31 (5 cases detected only with the Anyplex TM II HPV28 versus 0 cases detected with the Allplex TM HPV28, p = 0.07) and HPV39 (7 cases detected only with the Anyplex TM II HPV28 versus 1 case detected only with the Allplex TM HPV28, p = 0.08).

In the in vitro cell viability assay, anti-miR200b* showed a trend toward enhanced cytotoxicity slightly in cisplatin compared to the negative control (p = 0.07).

The incidence of lameness showed a trend towards being higher when owners used harmful practices in comparison to when they did not, χ 2 = (1, N = 57) = 3.26, p = 0.07.

Compared to WT eyes, rd10 mice showed a trend toward higher ferritin levels (1.5-fold, p = 0.07).

Paired samples t-tests showed that controls had greater alpha power in the right compared to the left hemisphere (t 20 = 2.45, p = .024 ), whereas patients showed a trend for greater alpha power in the left vs. right hemisphere (t 20 = −1.9, p = .07) ( Figure 2C , left panel).

Choosing the unknown object first when making a correct response showed a trend to be more likely with age, ρ(73) = 0.20, p = 0.07.

MR CaMKCre and MR-Tg female mice Both MR CaMKCre female mice and control littermates spent more time in the exit (target) quadrant than in the other quadrants, but MR CaMKCre females showed a trend for longer latency to the exit quadrant compared to their controls (56±15.4 vs 21±9.5; p = 0.070).

At baseline, the mean ABI was higher in the control group ( P = 0.02), and subjects entering the control group showed a trend toward higher scores on avoiding foot-damaging behaviors ( P = 0.07); both these biases would favor better outcomes in the control group.

Triglyceride levels showed a trend towards an increase after recovery only in the EAA group which was also elevated above baseline values (time-by-group, p = 0.070), Figure 1 e.

Semi-quantitative analysis of hepatic C3c protein levels by Western blotting showed a trend towards an increase in C3c protein levels in subjects with NASH as compared with subjects with healthy livers (2.29±0.57 vs. 1.35±0.50; p = 0.07; figure 2A ).

Pairwise comparisons showed a trend of Q2 > Q4 ( t (84) = 1.82, p = 0.070), which is reminiscent of previous findings ( Helfrich et al., 2018 ), but this result is not robust and should be treated as a negative finding.

The association between bridging and adverse events persisted in multivariate-adjusted analysis (Table 4 ): The use of bridging anticoagulation during interruption was significantly associated with an increase in bleeding events (adjusted OR, 3.84 for major bleeding or bleeding hospitalization; 95% confidence interval, 2.07–7.14; P <0.0001) and showed a trend toward increased cardiovascular events (adjusted OR, 1.62; 95% confidence interval, 0.95–2.78; P =0.07).

When considering only the cohort who were discharged “neurologically intact” (CPC score <3, n=107), ICD implantation showed a trend towards reduced all‐cause mortality in the multivariable analysis (HR 0.52 [0.25 to 1.05], P =0.07).

The effect of hormonal contraceptive on the first sample of salivary cortisol after waking showed a trend for lower levels in females taking contraceptives compared to those who were not (mean (SD) = 8.20 (3.42) vs. mean (SD) = 10.65 (4.37), F (1,17) = 3.74, p = 0.07); however, this difference was stable across days of testing and treatment groups (all interactions’ p values >0.7).

The number of branch points was significantly (P < 0.05) higher in testosterone treated cortical neurons, but only showed a trend for hypothalamic neurons (P<0.07).